Core Viewpoint - The acquisition of 90% stake in One Two Co., Ltd. by Youquhui Holdings for 2.701 billion yen (approximately 135 million HKD) marks a strategic move to establish a second growth curve for the company, enhancing its influence in the health consumption sector and integrating online and offline retail ecosystems [1][2][5]. Group 1: Acquisition Details - Youquhui has completed the acquisition of 90% of One Two Co., Ltd., which operates the Japanese pharmacy chain "あかひげ薬局" [1]. - The acquisition cost was 2.701 billion yen (approximately 135 million HKD), and the brand name and core team of あかひげ薬局 will be retained post-acquisition [1]. - あかひげ薬局 focuses on health management for middle-aged and elderly men, providing personalized health solutions through a one-on-one consultation model [3]. Group 2: Strategic Significance - The acquisition strengthens Youquhui's position in the high-potential health consumption market and provides access to a rare localized overseas brand [2]. - Youquhui aims to leverage the established retail network and expertise of あかひげ薬局 to transition from online operations to a hybrid online and offline retail ecosystem [2][4]. - The integration of Youquhui's digital capabilities with あかひげ薬局's professional services is expected to enhance operational efficiency and market reach [4]. Group 3: Growth Strategy - Youquhui has been actively building its second growth curve, previously launching the Canadian anti-aging health food brand Vanpearl and recruiting international experts to bolster its talent pool [6][7]. - The acquisition of あかひげ薬局 is seen as a natural extension of Youquhui's long-term strategy, enhancing its capabilities in research, brand management, and service delivery [7]. - The company is positioned to potentially engage in further acquisitions in the health consumption sector to strengthen its comprehensive capabilities across research, branding, and multi-channel operations [7][8].

Core Viewpoint - The acquisition of 90% stake in One Two Co., Ltd. by Youquhui Holdings for 2.701 billion yen (approximately 135 million HKD) marks a strategic move to establish a second growth curve for the company, enhancing its influence in the health consumption sector and integrating online and offline retail ecosystems [1][2][5]. Group 1: Acquisition Details - Youquhui has completed the acquisition of 90% of One Two Co., Ltd., which operates the Japanese pharmacy chain "あかひげ薬局" [1]. - The acquisition cost was 2.701 billion yen (approximately 135 million HKD), and the brand name and core team of あかひげ薬局 will be retained post-acquisition [1]. - あかひげ薬局 focuses on health management for middle-aged and elderly men, providing personalized health solutions through a one-on-one consultation model [3]. Group 2: Strategic Significance - The acquisition strengthens Youquhui's position in the high-potential health consumption market and provides access to a rare localized overseas brand [2]. - Youquhui aims to leverage the established retail network and expertise of あかひげ薬局 to transition from online operations to a hybrid online and offline retail model [2][4]. - The collaboration is expected to shorten the incubation period for developing proprietary brands and enhance competitive growth [2]. Group 3: Operational Synergies - Youquhui's extensive experience in the Japanese market and its established operational systems will facilitate the integration of あかひげ薬局 into its business model [4]. - The company plans to innovate service models, expand regional markets, and upgrade technology in collaboration with あかひげ薬局 [4]. - The focus will be on creating a comprehensive ecosystem that combines professional pharmaceutical services with intelligent health management across multiple markets in Asia [4]. Group 4: Growth Trajectory - Youquhui has been actively building its second growth curve, previously launching the Canadian anti-aging health food brand Vanpearl [6][7]. - The acquisition of あかひげ薬局 complements the establishment of a proprietary brand and enhances Youquhui's capabilities in research, brand management, and multi-channel operations [7]. - The company is expected to pursue further acquisitions in the health consumption sector to strengthen its full-chain capabilities [7][8]. Group 5: Market Positioning - The strategic moves by Youquhui are aligned with current market trends, positioning the company favorably amidst a slowing economic environment [8]. - The establishment of a new growth engine beyond its traditional business is anticipated to enhance the company's long-term investment value [8].

Group 1 - The company, Youquhui Holdings (02177.HK), announced a conditional agreement to acquire approximately 90% of One Two Co., Ltd. for a total consideration of 2,701,000,000 Japanese yen (approximately 135,050,000 Hong Kong dollars) [1] - Upon completion of the transaction, One Two Co., Ltd. will become an indirect non-wholly owned subsidiary of the company, and its financial performance will be consolidated into the group's financial statements [1] Group 2 - One Two Co., Ltd. is a limited company registered in Japan, primarily operating the leading consulting pharmacy chain brand Akahige Pharmacy, which specializes in sexual health and wellness [2] - The Akahige Pharmacy brand has been established in the Japanese market for over 33 years, with a network of more than 9 pharmacy locations across Hokkaido, Honshu, and Kyushu regions [2] - The pharmacy business focuses on providing personalized solutions for middle-aged and elderly men, addressing key health issues such as erectile dysfunction, premature ejaculation, and male menopause [2] - In addition to over-the-counter medications, the company has developed several proprietary sexual wellness products aimed at supporting the health and vitality of middle-aged and elderly men, including products like "Zhuangyang Huang" and "Qiangli Feidan" [2]